View in EDS HTML Full Text PDF Full Text

Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland.

Saved in:
Bibliographic Details
Title: Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland.
Authors: Bhadhuri A; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Klingelbergstrasse 61, CH-4056, Basel, Switzerland. Arjun.bhadhuri@unibas.ch., Dröschel D; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Klingelbergstrasse 61, CH-4056, Basel, Switzerland., Guldimann M; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Klingelbergstrasse 61, CH-4056, Basel, Switzerland., Jetschgo C; Novartis Pharma Schweiz AG, Rotkreuz, ZG, Switzerland., Banhazi J; Novartis Pharma AG, Basel, Switzerland., Schwenkglenks M; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Klingelbergstrasse 61, CH-4056, Basel, Switzerland., Sutherland CS; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Klingelbergstrasse 61, CH-4056, Basel, Switzerland.
Source: BMC health services research [BMC Health Serv Res] 2022 Jun 28; Vol. 22 (1), pp. 837. Date of Electronic Publication: 2022 Jun 28.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101088677 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6963 (Electronic) Linking ISSN: 14726963 NLM ISO Abbreviation: BMC Health Serv Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35765055
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bhadhuri+A%22">Bhadhuri A</searchLink>; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Klingelbergstrasse 61, CH-4056, Basel, Switzerland. Arjun.bhadhuri@unibas.ch.<br /><searchLink fieldCode="AU" term="%22Dröschel+D%22">Dröschel D</searchLink>; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Klingelbergstrasse 61, CH-4056, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Guldimann+M%22">Guldimann M</searchLink>; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Klingelbergstrasse 61, CH-4056, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jetschgo+C%22">Jetschgo C</searchLink>; Novartis Pharma Schweiz AG, Rotkreuz, ZG, Switzerland.<br /><searchLink fieldCode="AU" term="%22Banhazi+J%22">Banhazi J</searchLink>; Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schwenkglenks+M%22">Schwenkglenks M</searchLink>; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Klingelbergstrasse 61, CH-4056, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sutherland+CS%22">Sutherland CS</searchLink>; Institute of Pharmaceutical Medicine (ECPM), University of Basel, Klingelbergstrasse 61, CH-4056, Basel, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101088677%22">BMC health services research</searchLink> [BMC Health Serv Res] 2022 Jun 28; Vol. 22 (1), pp. 837. <i>Date of Electronic Publication: </i>2022 Jun 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101088677 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1472-6963 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214726963%22">14726963 </searchLink><i>NLM ISO Abbreviation: </i>BMC Health Serv Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35765055
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12913-022-08211-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 837
    Titles:
      – TitleFull: Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bhadhuri A
      – PersonEntity:
          Name:
            NameFull: Dröschel D
      – PersonEntity:
          Name:
            NameFull: Guldimann M
      – PersonEntity:
          Name:
            NameFull: Jetschgo C
      – PersonEntity:
          Name:
            NameFull: Banhazi J
      – PersonEntity:
          Name:
            NameFull: Schwenkglenks M
      – PersonEntity:
          Name:
            NameFull: Sutherland CS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 06
              Text: 2022 Jun 28
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1472-6963
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC health services research
              Type: main
ResultId 1